Mana.bio
San Francisco, CA
Mana.bio is an AI based drug delivery startup, creating a platform for Lipid Nanoparticle (LNP) development for oligonucleotide therapies including mRNA-based therapeutics, vaccines and gene therapy.
mana.bioCompany Details
Founded
- 2021
Employees
- Between 10 - 50 employees
Raised
- $29,500,000
Headquarters Location
- San Francisco, CA
Public
- No
Acquired
- No
CEO
Yogev Debbi
Founders
- Yogev DebbiRoy NevoKira Radinsky
Company Collections
These are collections Mana.bio is a part of. Click on the collection name to view similar companies.